Dolby Laboratories, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Dolby Laboratories, Inc. develops pioneering audio and imaging technologies that redefine entertainment and communication experiences across an expansive array of platforms. The company engineers and licenses a comprehensive suite of digital audio solutions, including Dolby AC-4, designed to deliver advanced audio to diverse playback environments. Its acclaimed sound technologies feature Dolby Atmos, recognized for its immersive, three-dimensional audio for cinematic presentations and a growing number of consumer devices. Additional audio codecs like Dolby Digital, Dolby Digital Plus, and Dolby TrueHD provide robust multichannel and lossless sound for various media applications, alongside efficient digital audio coding solutions such as AAC and HE-AAC. In visual technology, Dolby Vision offers an exceptional imaging experience, delivering ultra-vivid colors, striking contrast, and enhanced detail for both professional cinema and consumer devices. The company also provides essential digital video codecs like AVC and HEVC, ensuring high bandwidth efficiency across a wide range of media devices. For enhanced communication, Dolby Voice provides superior spatial audio and noise reduction for conferencing systems. Operating primarily on a licensing model, which accounts for the substantial majority of its revenue, Dolby grants manufacturers and content providers access to its proprietary intellectual property. Complementing this, Dolby Laboratories designs and manufactures specialized hardware, including digital cinema servers, processors, amplifiers, loudspeakers, and video conferencing solutions for the cinema, broadcast, and entertainment industries. Furthermore, it delivers a range of services supporting theatrical and television production, broadcast operations, and home entertainment. Dolby's extensive client base includes film studios, content creators, post-production facilities, cinema operators, broadcasters, video game developers, and numerous consumer electronics manufacturers integrating its technologies into televisions, mobile devices, PCs, soundbars, and, increasingly, automotive entertainment systems. Recent advancements in fiscal year 2025 include the expanded integration of Dolby Atmos and Dolby Vision into various automotive brands such as Audi, Tata, Mahindra, and Mercedes, and new smartphone models featuring Dolby Vision Capture. The company also continues to drive immersive experiences in major live sports broadcasts and streaming services. Founded by Ray Dolby in London in 1965, the company later established its headquarters in San Francisco, California, from where it continues its global operations.
Dividend Champion, Contender, And Challenger Highlights: Week August 16
Assenagon Asset Management S.A. Has $5.48 Million Position in Dolby Laboratories $DLB
Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?
Is Dolby Stock Worth Buying as Growth Meets Near-Term Execution Risks?
Why Dolby Labs Stock Popped Today
Dolby's Q3 Earnings Beat Estimates on Lower Operating Expenses
Dolby Laboratories Q3 Earnings Call Highlights
Dolby Laboratories (DLB) Q3 Earnings Beat Estimates
Dolby Laboratories (DLB) Reports Q3 Earnings: What Key Metrics Have to Say
Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript
Dolby Laboratories Reports Third Quarter 2026 Financial Results
Aristotle Global Equity Advisory Q2 2026 Portfolio Review
Dolby Laboratories Valuation Is Compelling Ahead Of Earnings
Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2026 Financial Results
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
3 Audio Video Stocks to Watch as Industry Witnesses Headwinds